Celiac disease may be the most widely known autoimmune condition, but there are still many questions to be answered about genetics, microbiota, diagnostics, the gluten-free diet, and other potential treatments.
At the September 2019 ICDS Conference in Paris, France, many of the foremost experts in celiac disease presented their work on various topics to rooms full of gastroenterologists, pediatricians, dieticians, and celiac-related organizations and programs. It was a packed few days, illuminating a number of controversies in the realm of celiac disease, IBS, and non-celiac gluten sensitivity.
Even at a conference centered around celiac disease, some of the options offered in the gluten-free lunch boxes listed wheat flour, barley, and “may contain gluten” on their ingredient labels. And fresh fruit was placed underneath gluten-containing croissants. The food situation for celiac attendees brought attention to the challenge of being on a gluten-free diet, and the lack of public knowledge about it. It’s no surprise that the need for this kind of vigilance can tempt individuals toward either hypervigilance or nonadherence, topics discussed at length during the conference.
Psychological Issues, Caroline Ciacci and audience comments
Update on NCGS, Knut Lundin
Mechanistic Insight into the Role of Microbiota in Intestinal Inflammation, Harry Sokol
Follow-Up of the Patient: Which Balance for the Best Compliance?, Benjamin Lebwohl
Sign up for resources, insights, and updates on autoimmune disease and living with chronic illness.